Microorganism |
MIC50 (μg/ml) |
MIC90 (μg/ml) |
Range (μg/ml) |
Antimicrobial  |
Reference |
Escherichia coli |
0.031 |
0.5 |
≤0.004 - 2 |
Gatifloxacin (Tequin)  |
443 |
Escherichia coli |
0.032 |
0.063 |
0.016 - 0.125 |
Cefpirome  |
952 |
Escherichia coli |
0.032 |
0.063 |
0.032 - 0.063 |
Biapenem  |
952 |
Escherichia coli |
0.045 |
0.091 |
? - ? |
Ceftobiprole (Zeftera)  |
942 |
Escherichia coli |
0.05 |
0.1 |
≤0.00625 - 0.2 |
Garenoxacin (T-3811, BMS-284756)  |
17 |
Escherichia coli |
0.05 |
25 |
≤0.025 - 50 |
Levofloxacin (Levaquin, Quixin)  |
40 |
Escherichia coli |
0.06 |
0.06 |
0.03 - 0.12 |
Sparfloxacin (AT-4140, Zagam)  |
374 |
Escherichia coli |
0.06 |
0.06 |
0.03 - 0.25 |
Cefotaxime (Cephotaxime, Claforan)  |
1438 |
Escherichia coli |
0.06 |
0.12 |
≤0.007 - 64 |
Cefotaxime (Cephotaxime, Claforan)  |
113 |
Escherichia coli |
0.06 |
0.12 |
0.015 - 2 |
Cefmenoxime  |
1438 |
Escherichia coli |
0.06 |
0.12 |
≤0.06 - >8 |
Ceftriaxone (Rocephin)  |
462 |
Escherichia coli |
0.06 |
0.12 |
? - ? |
Cefotaxime (Cephotaxime, Claforan)  |
1389 |
Escherichia coli |
0.06 |
0.125 |
0.016 - 0.125 |
Levofloxacin (Levaquin, Quixin)  |
317 |
Escherichia coli |
0.06 |
0.13 |
? - ? |
Ceftriaxone (Rocephin)  |
1111 |
Escherichia coli |
0.06 |
0.25 |
0.015 - 8 |
Ceftibuten (Cedax)  |
274 |
Escherichia coli |
0.06 |
0.25 |
0.03 - 2 |
FK037  |
1491 |
Escherichia coli |
0.06 |
0.25 |
<0.03 - >128 |
LY127935  |
1434 |
Escherichia coli |
0.06 |
0.25 |
≤0.06 - >64 |
Ceftriaxone (Rocephin)  |
42 |
Escherichia coli |
0.06 |
0.25 |
≤0.06 - >=128 |
Ceftriaxone (Rocephin)  |
475 |
Escherichia coli |
0.06 |
0.25 |
? - ? |
Cefmenoxime  |
1389 |
Escherichia coli |
0.06 |
0.25 |
? - ? |
Moxalactam (Latamoxef)  |
1389 |
Escherichia coli |
0.06 |
0.5 |
≤0.06 - >32 |
Meropenem (Merrem)  |
1371 |
Escherichia coli |
0.06 |
1 |
≤0.004 - 8 |
Moxifloxacin (BAY 12-8039, Avelox)  |
130 |
Escherichia coli |
0.06 |
1 |
≤0.004 - 8 |
Moxifloxacin (BAY 12-8039, Avelox)  |
443 |
Escherichia coli |
0.06 |
1 |
≤0.004 - 16 |
Garenoxacin (T-3811, BMS-284756)  |
443 |
Escherichia coli |
0.06 |
1 |
≤0.004 - 16 |
Garenoxacin (T-3811, BMS-284756)  |
130 |
Escherichia coli |
0.06 |
1 |
0.015 - >64 |
Garenoxacin (T-3811, BMS-284756)  |
225 |
Escherichia coli |
0.06 |
2 |
0.06 - ? |
Co-trimoxazole (Trimethoprim-sulfamethoxazole, TMP-SMX)  |
946 |